Canadian Symposia on Rare Bone Diseases 2022*

COMPLIMENTARY VIRTUAL CPD WEBINAR

TARGET AUDIENCE

Metabolic Bone Disease specialists, Endocrinologists, Geriatricians, Rheumatologists, Internists, Pediatricians, Physiatrists, Orthopedic Surgeons, Radiologists, Fellows, Residents and Medical Students, Interested Family Physicians.

LEARNING OBJECTIVES

At the end of this learning activity, the participants will be able to:

Know the advances in the diagnosis and management of Hypophosphatasia.
Understand how to evaluate and treat X-linked Hypophosphatemia and Tumour Induced Osteomalacia.
Know how to diagnose Fibrodysplasia Ossificans Progressiva and the underlying pathophysiology.

ACCREDITATION STATEMENTS

McMaster University, Continuing Professional Development Program (CPD) is fully accredited by the Committee on Accreditation of Continuing Medical Education (CACME) to provide CFPC Mainpro+ and RCPSC Maintenance of Certification (MOC) study credits for Continuing Medical Education.

This one-credit-per-hour Group-Learning program meets the certification criteria of the College of Family Physicians of Canada and has been certified by the McMaster University Continuing Professional Development Program for up to 3.5 Mainpro+ credits.

This activity is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by McMaster University Continuing Professional Development Program. You may claim a maximum of 3.5 MOC Section 1 hours (credits are automatically calculated).

Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 Credits™. Information on the process to convert Royal College MOC credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.

Each attendee should only claim the hours they attended.